FTC Signals to Health Software Companies an Intention to Increase Scrutiny over Advertising Claims

The FTC has just reached a settlement with Lumos Labs over claims that the company was deceptively advertising the health benefits of its Luminosity software program.  The FTC’s action over this issue should serve as a warning to the health software industry regarding how health software companies are advertising their products.   I addressed this issue in more detail in the follow blog post for the Silicon Valley Software Law Blog:

FTC Settles with Lumos Labs.


Print Friendly, PDF & Email

Leave a Comment